Public Resource Links to Information regarding COVID-19 Testing & Vaccination access →

LSU Health Shreveport (LSUHS) has been leading Louisiana and much of the nation in its COVID-19 response. Beginning in March of 2020 with the creation of the Emerging Viral Threat Lab, a high-capacity, PCR lab which quickly enabled robust COVID-19 testing in north Louisiana. This noteworthy accomplishment was followed by life-saving clinical trials, expanded testing and ultimately large scale community vaccination clinics to include outreach to the medically underserved.  Currently LSU Health Shreveport is being nationally and internationally recognized for their significant contributions to sequencing of the virus and recent discovery of 7 new variants.


 

  TRAVEL RECOMMENDATIONS

FULLY VACCINATED TRAVELERS: CDC recommends wearing a mask over your nose and mouth is required on planes, buses, trains, and other forms of public transportation domestically but not in outdoor areas. Follow state and local recommendations for masks and social distancing. AFTER TRAVEL - self monitor for COVID-19 symptoms; isolate and get tested if symptoms develop.

UNVACCINATED TRAVELERS: CDC recommends to get tested 1 to 3 days before your trip - click here for testing locations. Travelers who are not fully vaccinated should wear a mask and maintain physical distancing on all transportation; avoid crowds and stay at least 6 feet from anyone not traveling with you. Wash hands often or use hand sanitizer. AFTER TRAVEL - get tested within 3 to 5 days AND stay home and self-quarantine for a full 7 days, even if test is negative. 

Learn more about travel recommendations AND travel restriction during COVID-19 on CDC.GOV


 

GENOME SEQUENCING

LSU Health Shreveport obtains complete genome sequences of the viruses in cooperation with national and international efforts to understand the virus, enable molecular epidemiology work, and to inform future vaccine efforts. LSUHS is the only academic center in Louisiana with this capability

→ Link to SEQUENCING INFORMATION

CLINICAL TRIALS

Serving as the only Pfizer vaccine trial site in north central Louisiana.  LSU Health Shreveport has reached every benchmark of the Pfizer trial in record time. Currently, the trial is accepting individuals ages 13-18 with an expectation to include younger children and pregnant women in the near future.

→ LINK TO COVID-19 CLINICAL TRIALS

CEVT

Center of Excellence for Emerging Viral Threats has a highly reliable COVID-19 testing lab with the capacity to process up to 1,500 tests/day. The Lab was the first testing lab to be established at an academic medical center in Louisiana and is led by internationally and nationally renowned NIH-funded scientists.

→ LINK TO Cevt

COVID-19 Research News at LSUHS

   

LSU Health Shreveport Leads Louisiana Response
to COVID-19

SARS-CoV-2 Viral Genome Sequencing

Only academic center in Louisiana to obtain complete genome sequences of the viruses and work with WHO and CDC-sanctioned testing labs

Doctor gives COVID-19 vaccine to woman in car

COVID-19 Vaccinations

First large scale vaccine clinic in Louisiana providing 30,000 vaccinations as of 2/25/2021

Photo: Scientists at work in the LSU Health Shreveport EVT Lab

Center of Excellence for Emerging Viral Threats

First testing lab to be established at an Academic Medical Center in Louisiana

COVID-19 TESTING

More than 280,000 COVID-19 tests administered by LSU Health Shreveport

Inhaled Nitric Oxide Clinical Trial

First site in Louisiana and second in the U.S. to offer inhaled nitric oxide clinical trial

Convalescent Plasma Therapy

First site in Louisiana and one of earliest in the U.S. to offer convalescent plasma to critically ill patients

Serology Testing

Supporting COVID-19 Clinical Trials, Therapies and Research